Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Completed · Phase 2 · Has a placebo group
Conditions studied: Benign Prostatic Hyperplasia
In brief
The purpose of this study is to evaluate the safety and efficacy of various fixed daily doses of WC3055 compared with placebo for the treatment of subjects with LUTS secondary to BPH.
Key facts
- Study ID
- NCT01939184
- Run by
- Warner Chilcott
- People needed
- 796
- Starts
- 2013-08-01
- Expected to finish
- 2014-04-01
- Last updated by the study team
- 2015-06-29
Who can join
Age: 45 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- History of LUTS for ≥6 months secondary to BPH
- Total IPSS (International Prostate Symptom Score) ≥ 13 at Screening
Where it is running
- Warner Chilcott Investigational Study Site — Huntsville, Alabama, United States
- Warner Chilcott Investigational Study Site — Mobile, Alabama, United States
- Warner Chilcott Investigational Study Site — Chandler, Arizona, United States
- Warner Chilcott Investigational Study Site — Gilbert, Arizona, United States
- Warner Chilcott Investigational Study Site — Glendale, Arizona, United States
- Warner Chilcott Investigational Study Site — Phoenix, Arizona, United States
- Warner Chilcott Investigational Study Site — Laguna Hills, California, United States
- Warner Chilcott Investigational Study Site — Murrieta, California, United States
- Warner Chilcott Investigational Study Site — San Diego, California, United States
- Warner Chilcott Investigational Study Site — San Diego, California, United States
- Warner Chilcott Investigational Study Site — San Diego, California, United States
- Warner Chilcott Investigational Study Site — San Diego, California, United States
- Warner Chilcott Investigational Study Site — Colorado Springs, Colorado, United States
- Warner Chilcott Investigational Study Site — Denver, Colorado, United States
- Warner Chilcott Investigational Study Site — Denver, Colorado, United States
- Warner Chilcott Investigational Study Site — Denver, Colorado, United States
- Warner Chilcott Investigational Study Site — Englewood, Colorado, United States
- Warner Chilcott Investigational Study Site — Parker, Colorado, United States
- Warner Chilcott Investigational Study Site — Middlebury, Connecticut, United States
- Warner Chilcott Investigational Study Site — New Britain, Connecticut, United States
- Warner Chilcott Investigational Study Site — Aventura, Florida, United States
- Warner Chilcott Investigational Study Site — Clearwater, Florida, United States
- Warner Chilcottt Investigational Study Site — Clearwater, Florida, United States
- Warner Chilcott Investigational Study Site — Hialeah, Florida, United States
- Warner Chilcott Investigational Study Site — Homewood, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.